• 
  Cathy Pichol-Thievend, Oceane Anezo, Aafrin Pettiwala, Guillaume Bourmeau, Remi Montagne, et al.. VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance. Nature Communications, 2024, 15 (1), pp.3602. ⟨10.1038/s41467-024-47985-z⟩. ⟨hal-04648492⟩
• 
  Caroline Hoffmann, Floriane Noel, Maximilien Grandclaudon, Lucile Massenet-Regad, Paula Michea, et al.. PD-L1 and ICOSL discriminate human Secretory and Helper dendritic cells in cancer, allergy and autoimmunity. Nature Communications, 2022, 13 (1), pp.1983. ⟨10.1038/s41467-022-29516-w⟩. ⟨hal-03989545⟩
• 
  Simona Catozzi, Souad Assaad, Lidia Delrieu, Bertrand Favier, Elise Dumas, et al.. Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An In-depth chronotherapeutic study. European Journal of Cancer, 2024, 199, pp.113571. ⟨10.1016/j.ejca.2024.113571⟩. ⟨hal-04622174⟩
• 
  M Mangiardi-Veltin, D Hequet, J Mullaert, M Zins, M Goldberg, et al.. Sexualité féminine après cancer du sein : données de vie réelle à partir de la cohorte Constances. Etude EXISTENCE. Pari(s) Santé Femmes, Jan 2023, Paris, France. ⟨hal-04611465⟩
• 
  Marc Michel, Maryam Heidary, Anissa Mechri, Kévin Da Silva, Marine Gorse, et al.. Non-invasive multi-cancer diagnosis using DNA hypomethylation of LINE-1 retrotransposons. 2024. ⟨hal-04453898⟩

397

246